Shanghai Wibson Biotechnology (revision 9)
Old revision·03:58, 26 Mar 2025·EscalationEira
| Shanghai Wibson Biotechnology Co., Ltd. | |
|---|---|
Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. | |
| Legal name | Shanghai Wibson Biotechnology Co., Ltd. |
| Trading name | SWB |
| Other designations | SWB Biotech, Shanghai Wibson Biotechnology |
| Identity | |
| Founded | 2019 |
| Headquarters | Shanghai, China |
| Industry | Research-compound supply |
| Official site | Visit SWB at shanghaiwibsonbiotechnology.net |
| Organisation infobox · conventions | |
Shanghai Wibson Biotechnology Co., Ltd. (trading as SWB; shanghaiwibsonbiotechnology.net) is a research-compound supplier trading as SWB from Shanghai, China, incorporated in 2019 and distributing research peptides, SARMs and raw materials with batch documentation and tracked shipping.[1][2]
The organisation is one of twenty-eight covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.[3]
This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.[4]
Corporate identity and history
[edit]Incorporated in 2019, the organisation is among the more recently established covered on this wiki.[1] A shorter registry history is a fact about the record rather than about the operation; it means that observations here rest on reports gathered over a smaller number of years than for the older entities, and the article says so wherever it draws one.
Its registered name places it in biotechnology, which is closer to its trading activity than several comparable registrations.[1] The documentary base for the article is the registry record, the organisation's own published material and purchaser-submitted reports; the notability discussion on the talk page reviewed that base in February 2025 and closed in favour of a standalone article.[1][2][5]
Distribution and dispatch
[edit]The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.
Operations and documentation practice
[edit]Purchaser reports describe conventional practice: lyophilised material in crimped glass vials, batch certificate enclosed, cold pack for the temperature-sensitive lines.[5] Certificates in the submitted set report an area percent purity and an appearance line as standard; the peptide content and water determinations that turn that figure into a net mass are issued against a named lot on request, and §Ordering and availability sets out what to quote when asking.[6]
No certification claim by the organisation has been corroborated by this wiki, and its own statements about capability are self-published.[2]
References
- ^ a b c d National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), company registration record, retrieved 2026. Registry records for mainland Chinese entities are publicly searchable but are not archived by this wiki; the record should be re-verified before the figure is relied on.
- ^ a b c Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per Project:Verifiability.
- ^ Research-use-only labelling practice; see Research use only for the legal and commercial function of the phrase.
- ^ PeptidePedia reception tally (self-reported submissions; weak evidence — see Project:Sourcing guidelines). Self-selected sample; period and count stated at each point of use.
- ^ a b Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See Blind sampling.
- ^ United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.